A molecular "silencer" makes leukemia cells invisible
The discovery paves the way for new treatments of AML relapses post transplantation
MOREPromising preclinical results for TCR T-cells in AML
The first clinical trial in AML patients, sponsored by Intellia Therapeutics, already began in UK and USA
MORERemoving cancer "sugar shield" improves CAR T efficacy
The layer of sugars surrounding cancer cells plays a key role in protecting them from the immune system
MOREHighlights
Immunotherapy for liver metastasis from colorectal cancer
From San Raffaele, a new immunotherapeutic strategy to prevent liver metastasis from...
New mechanism of interaction between nerves and blood vessels during embryonic development
In a study published on Neuron, researchers identified one of the fundamental...
The first neutrophil atlas
A research team from SR-Tiget generated for the first time a complete mapping of human...
Research Highlights
Great research leads to great results. Our pioneering science in numbers.
Research integrity
Upholding high standards of quality, trustworthiness and reproducibility
Industry collaborations
Join the excellence. Explore our integrated biomedical innovation pipeline.
Science outreach
Bridging the gap between science and society, for the benefit of both.